02 / 2026 FORTBILDUNG: THEMENHEFTTEIL KINDERÄRZTE. SCHWEIZ 27 31 Donix, K. L.; Bauer, M. Referenz Psychische Störungen. Artifizielle Störungen. Münchhausen-by-proxy-Syndrom. Thieme, Stuttgart, 2021. doi.org/10.1055/b-0041-181933 (abgerufen am 18. Mai 2026). 32 Peo, L. C.; Wiehler, K.; Paulick, J.; et al. «Pediatric and adult patients with ME/CFS following COVID-19: A structured approach to diagnosis using the Munich Berlin Symptom Questionnaire (MBSQ)». European Journal of Pediatrics 2024;183(3):1265– 1276. doi.org/10.1007/s00431-023-05351-z (abgerufen am 18. Mai 2026). 33 Rowe, P. C.; Underhill, R. A.; Friedman, K. J.; et al. «Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Diagnosis and Management in Young People: A Primer». Frontiers in Pediatrics 2017;5:121. doi.org/10.3389/fped.2017.00121 (abgerufen am 18. Mai 2026). 34 Melfsen, S.; Lucas, T. «CFS/ME als ideale Fassade für das Münchhausen-by-Proxy-Syndrom? – ‹Auch Ausruhen kann anstrengend sein …›». Monatsschrift Kinderheilkunde 2025;173(Suppl 4):316–319. doi.org/10.1007/s00112-024-02113-5 (abgerufen am 18. Mai 2026). 35 Evans, W. N.; Muchnick, K.; Rosenlund, O. «Virtual Learning in Kindergarten Through Grade 12 During the COVID-19 Pandemic and Chronic Absenteeism». JAMA Network Open 2024;7(8):e2429569. doi.org/10.1001/jamanetworkopen. 2024.29569 (abgerufen am 18. Mai 2026). 36 Mohler-Kuo, M.; Dzemaili, S.; Foster, S.; Werlen, L.; Walitza, S. «Stress and Mental Health among Children/Adolescents, Their Parents, and Young Adults during the First COVID-19 Lockdown in Switzerland». International Journal of Environmental Research and Public Health 2021;18(9):4668. doi.org/10.3390/ ijerph18094668 (abgerufen am 18. Mai 2026). 37 Dey, M.; Volken, T.; Altwicker-Hámori, S.; et al. «Did the COVID-19 pandemic impact paediatric health service utilisation in Switzerland? Interrupted time-series models of health insurance data». Swiss Medical Weekly 2025;155:3899. doi.org/10.57187/s.3899 (abgerufen am 18. Mai 2026). 38 Ravens-Sieberer, U.; Kaman, A.; Erhart, M.; Devine, J.; Schlack, R.; Otto, C. «Impact of the COVID-19 pandemic on quality of life and mental health in children and adolescents in Germany». European Child & Adolescent Psychiatry 2022;31(6):879–889. doi.org/10.1007/s00787-021-01726-5 (abgerufen am 18. Mai 2026). 39 Borgschulte, M.; Chen, Y. «Youth disconnection during the COVID-19 pandemic». Labour Economics 2022;78:102241. doi.org/10.1016/j.labeco.2022.102241 (abgerufen am 18. Mai 2026). 40 Bedir Demirdag, T.; Ozcicek, M.; Polat, M.; et al. «Effects of COVID-19 pandemic on epidemiological features of viral respiratory tract infections in children: a single-centre study». Epidemiology & Infection 2024;152:e128. doi.org/10.1017/ S0950268824001158 (abgerufen am 18. Mai 2026). 41 Bedir Demirdag, T.; Ozcicek, M.; Polat, M.; et al. «Effects of COVID-19 pandemic on epidemiological features of viral respiratory tract infections in children: a single-centre study». Epidemiology & Infection 2024;152:e128. doi.org/10.1017/ S0950268824001158 (abgerufen am 18. Mai 2026). 42 Bardsley, M.; Morbey, R. A.; Hughes, H. E.; et al. «Epidemiology of respiratory syncytial virus in children younger than 5 years in England during the COVID-19 pandemic, measured by laboratory, clinical, and syndromic surveillance: a retrospective observational study». The Lancet Infectious Diseases 2023;23(1): 56–66. doi.org/10.1016/S1473-3099(22)00525-4 (abgerufen am 18. Mai 2026). 43 Wong, L. Y.; Perlman, S. «Immune dysregulation and immunopathology induced by SARS-CoV-2 and related coronaviruses — are we our own worst enemy?». Nature Reviews Immunology 2022;22:47–56. doi.org/10.1038/s41577-021-00656-2 (abgerufen am 18. Mai 2026). 44 Rotulo, G. A.; Palma, P. «Understanding COVID-19 in children: immune determinants and post-infection conditions». Pediatric Research 2023;94:434–442. doi.org/10.1038/s41390-02302549-7 (abgerufen am 18. Mai 2026). 45 Office for National Statistics (ONS). «New-Onset, Self-Reported Long COVID after Coronavirus (COVID-19) Reinfection in the UK: 23 February 2023». ONS. ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/newonsetselfreportedlongcovidaftercoronaviruscovid19reinfectionintheuk/23february2023 (abgerufen am 18. Mai 2026). 46 Pretorius, E.; Vlok, M.; Venter, C.; et al. «Persistent clotting protein pathology in Long COVID/Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin». Cardiovascular Diabetology 2021;20(1):172. doi.org/10.1186/ s12933-021-01359-7 (abgerufen am 18. Mai 2026). 47 Charfeddine, S.; Ibn Hadj Amor, H.; Jdidi, J.; et al. «Long COVID 19 Syndrome: Is It Related to Microcirculation and Endothelial Dysfunction? Insights From TUN-EndCOV Study». Frontiers in Cardiovascular Medicine 2021;8:745758. doi.org/ 10.3389/fcvm.2021.745758 (abgerufen am 18. Mai 2026). 48 Stein, S. R.; Ramelli, S. C.; Grazioli, A.; et al. «SARS-CoV-2 infection and persistence in the human body and brain at autopsy». Nature 2022;612(7941):758–763. doi:10.1038/s41586-02205542-y. (abgerufen am 18. Mai 2026). 49 Gaebler, C.; Wang, Z.; Lorenzi, J. C. C.; et al. «Evolution of antibody immunity to SARS-CoV-2». Nature 2021;591 (7851):639–644. doi.org/10.1038/s41586-021-03207-w (abgerufen am 18. Mai 2026). 50 Cheung, C. C. L.; Goh, D.; Lim, X.; et al. «Residual SARS-CoV-2 viral antigens detected in GI and hepatic tissues from five recovered patients with COVID-19». Gut 2022;71(1):226–229. doi. org/10.1136/gutjnl-2021-324280 (abgerufen am 18. Mai 2026). 51 Scoullar, M. J.; Khoury, G.; Majumdar, S. S.; Tippett, E.; Crabb, B. S. «Towards a cure for long COVID: the strengthening case for persistently replicating SARS-CoV-2 as a driver of postacute sequelae of COVID-19». Medical Journal of Australia 2024;221(11):587–590. doi.org/10.5694/mja2.52517 (abgerufen am 18. Mai 2026). 52 Peluso, M. J.; Lu, S.; Tang, A. F.; et al. «Markers of Immune Activation and Inflammation in Individuals With Postacute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 Infection». The Journal of Infectious Diseases 2021;224(11):1839–1848. doi.org/10.1093/infdis/jiab490 (abgerufen am 18. Mai 2026). 53 Schultheiß, C.; Willscher, E.; Paschold, L.; et al. «The IL-1ß, IL-6, and TNF cytokine triad is associated with post-acute sequelae of COVID-19». Cell Reports Medicine 2022;3(6):100663. doi. org/10.1016/j.xcrm.2022.100663 (abgerufen am 18. Mai 2026). 54 Phetsouphanh, C.; Darley, D. R.; Wilson, D. B.; et al. «Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection». Nature Immunology 2022;23(2):210–216. doi.org/10.1038/s41590-021-01113-x (abgerufen am 18. Mai 2026). 55 Karlsson, A. C.; Humbert, M.; Buggert, M. «The known unknowns of T cell immunity to COVID-19». Science Immunology 2020;5(53):eabe8063. doi.org/10.1126/sciimmunol.abe8063 (abgerufen am 18. Mai 2026). 56 Liu, Q.; Mak, J. W. Y.; Su, Q.; et al. «Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome». Gut 2022;71(3):544–552. doi.org/10.1136/ gutjnl-2021-325989 (abgerufen am 18. Mai 2026). 57 Fernández-Castañeda, A.; Lu, P.; Geraghty, A. C.; et al. «Mild respiratory SARS-CoV-2 infection can cause multi-lineage cellular dysregulation and myelin loss in the brain». bioRxiv (Preprint) 2022. doi.org/10.1101/2022.01.07.475453 (abgerufen am 18. Mai 2026).
RkJQdWJsaXNoZXIy MjYwNzMx